Lincomycin Injection USP 600MG/2ML

Antibiotic – Lincosamide

Lincomycin Injection USP 600mg/2mL is a sterile injectable antibiotic manufactured in compliance with United States Pharmacopeia (USP) standards. It belongs to the lincosamide class of antibiotics and is primarily effective against Gram-positive bacteria and certain anaerobic organisms. This injectable formulation is used in hospital and surgical settings for the management of serious bacterial infections, especially when penicillin therapy is not appropriate. It may also be used in bone and joint infections due to its good tissue penetration. Lincomycin Injection USP ensures quality, potency, and therapeutic reliability for hospital-based care.

Key Information

Active Ingredient Lincomycin (600 mg/2 mL)

Dosage Form Injection

Pack Size 2 mL Vial

Storage Controlled room temperature.

Benefits

Effective against serious Gram-positive infections

Suitable alternative in penicillin-allergic patients (if appropriate)

Good bone and tissue penetration

Rapid bacteriostatic action

USP-compliant sterile injectable formulation

Usage Instructions

Administered intramuscularly (IM) or intravenously (IV) by healthcare professionals

Dosage depends on infection severity and patient condition

Slow IV infusion recommended

Complete full course of therapy as prescribed

Mechanism of Action

Lincomycin inhibits bacterial protein synthesis by binding to the 50S ribosomal subunit, preventing peptide chain elongation. It is primarily bacteriostatic but may be bactericidal at higher concentrations.

Indications

Lincomycin Injection USP 600mg/2mL is indicated for the treatment of serious infections caused by susceptible bacteria, including:

Severe respiratory tract infections

Skin and soft tissue infections

Bone and joint infections (osteomyelitis)

Septicemia

Postoperative infections

Infections caused by Gram-positive organisms

Side Effects

Possible side effects include:

Diarrhea

Nausea

Abdominal pain

Injection site irritation

Rash

Rare cases of pseudomembranous colitis

Precautions

Monitor for signs of antibiotic-associated colitis

Use cautiously in patients with hepatic or renal impairment

Avoid unnecessary prolonged use

Regular monitoring may be required during extended therapy

Contraindications

Hypersensitivity to lincomycin or clindamycin

History of antibiotic-associated colitis

Severe hepatic impairment (use with caution)

Severe renal impairment without monitoring